View drug registration information details.


ItemsRegistration information
ID464
No464
Brand NameMONVEX-L
IngredientsLevocetirizine Dihydrochloride USP 5 mg, Montelukast Sodium Eq. to. Montelukast BP 10 mg
Dosage FormFilm coated Tablets
Primary PackagingAlu-Alu Blister
StorageStore below 30°C. Protect from light.
Shelf Life3 YEARS
Pack SizeBOX OF 3 X 10'S
Dispensing CategoryPRESCRIPTION
ATC Classification
Pharmaceutical ClassANTIHISTAMINES & ANTIALLERGICS
Indicationsfor the relief of symptoms associated with seasonal and perennial allergic rhinitis.
ContraindicationsMontelukast plus Levocetirizine is contraindicated in patients with known hypersensitivity to Montelukast or Levocetirizine, patients with severe (creatinine clearance less than 10 ml/min) or hepatic impairment, in children 6- 11 years of age with renal impairment, and women who are pregnant or breastfeeding.
Side EffectsNausea, Skin rash, Diarrhoea, Vomiting, Dry mouth, Headache, Skin rash, Fatigue (Weakness), Fever, Abdominal pain, Dyspepsia, Dizziness, Congestion.
Unit Price
EDL No
DescriptionA yellow colored, round shaped, biconvex, film Coated tablet, plain on both side.
Note
License OwnerVE PRODUCTS (LAO) CO.,LTD
Manufacturer4Care Lifescience Pvt. Ltd.
CountryINDIA
Import Registration NoG/25/2400
Import Registration Date19-03-2024
ActivityCERTIFICATE RELEASED
Applied Date2024-10-15
FDD Registration No12 I 5835/24
FDD Registration Date2024-12-30
Expiry Date2029-12-29

Back to drug list